A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
Public ClinicalTrials.gov record NCT03816163. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-Label, Randomized Study to Assess the Efficacy and Safety of Zolbetuximab (IMAB362) in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Study identification
- NCT ID
- NCT03816163
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Astellas Pharma Global Development, Inc.
- Industry
- Enrollment
- 393 participants
Conditions and interventions
Interventions
- gemcitabine Drug
- nab-paclitaxel Drug
- zolbetuximab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2019
- Primary completion
- Aug 30, 2026
- Completion
- Aug 30, 2026
- Last update posted
- Mar 11, 2026
2019 – 2026
United States locations
- U.S. sites
- 25
- U.S. states
- 14
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph Heritage Medical Group | Fullerton | California | 92835 | — |
| TOI Clinical research | Whittier | California | 90603 | — |
| Midstate Medical Center | Meriden | Connecticut | 06451 | — |
| Lynn Cancer Institute | Boca Raton | Florida | 33486 | — |
| Baptist Health | Miami | Florida | 33176 | — |
| Cancer Treatment Centers of Atlanta | Newnan | Georgia | 30265 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| Norton Cancer Institute (NCI) | Louisville | Kentucky | 40202 | — |
| Ochsner Health System | New Orleans | Louisiana | 70121 | — |
| David C Pratt Cancer Center | Creve Coeur | Missouri | 63141 | — |
| Memorial Sloan Kettering Basking Ridge | Basking Ridge | New Jersey | 07920 | — |
| Memorial Sloan Kettering Bergen | Montvale | New Jersey | 07645 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14203 | — |
| Memorial Sloan Kettering Commack | Commack | New York | 11725 | — |
| Memorial Sloan Kettering Westchester | Harrison | New York | 10604 | — |
| Northwell Health Cancer Institute | Lake Success | New York | 11042 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10022 | — |
| Memorial Sloan Kettering Nassau | Uniondale | New York | 11553 | — |
| Novant Health Presbyterian Medical Center | Charlotte | North Carolina | 28204 | — |
| Novant Health | Winston-Salem | North Carolina | 27103 | — |
| Houston Methodist Hospital | Houston | Texas | 77030 | — |
| Utah Cancer Specialists | Salt Lake City | Utah | 84106 | — |
| MultiCare Regional Cancer Center - Gig Harbor | Gig Harbor | Washington | 98335 | — |
| Vista Oncology | Olympia | Washington | 98502 | — |
| Virginia Mason | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 111 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03816163, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 11, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03816163 live on ClinicalTrials.gov.